These Numbers Reveal How Powerful Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) Stock Is

The trading price of Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) closed higher on Friday, June 17, closing at $1.05, 10.53% higher than its previous close.

Traders who pay close attention to intraday price movement should know that it fluctuated between $0.95 and $1.09. In examining the 52-week price action we see that the stock hit a 52-week high of $9.54 and a 52-week low of $0.92. Over the past month, the stock has lost -0.94% in value.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Corvus Pharmaceuticals Inc., whose market valuation is $51.61 million at the time of this writing, is expected to release its quarterly earnings report Mar 23, 2022 – Mar 28, 2022. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.18 per share this quarter, however they have predicted annual earnings per share of -$0.84 for 2022 and -$1.03 for 2023. It means analysts are expecting annual earnings per share growth of 18.40% this year and -22.60% next year.

A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Corvus Pharmaceuticals Inc. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest CRVS has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.

A quick review shows that CRVS’s price is currently 1.68% off the SMA20 and -14.06% off the SMA50. The RSI metric on the 14-day chart is currently showing 47.70, and weekly volatility stands at 8.95%. When measured over the past 30 days, the indicator reaches 8.41%. Corvus Pharmaceuticals Inc. (NASDAQ:CRVS)’s beta value is currently sitting at 1.07, while the Average True Range indicator is currently displaying 0.09.

To see how Corvus Pharmaceuticals Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: CRVS stock’s performance was 10.53% in the latest trading, and -61.54% in the past year. Another comparable company Omeros Corporation (OMER) saw its stock close 4.17% higher in the most recent trading session but was down -86.72% in a year. Also in last trading session, the S&P 500 Index has surged 0.22%, while the Dow Jones Industrial also saw a negative session, down -0.13% on the day.

An evaluation of the daily trading volume of Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) indicates that the 3-month average is 248.45K.

Currently, records show that 46.55 million of the company’s shares remain outstanding. The insiders hold 0.10% of outstanding shares, whereas institutions hold 59.30%. However, since the stock’s price has seen -56.43% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.